Medicines planning
47 results
Applied filters
Planning
We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.
Costing clinical trials of ATIMPs using the NIHR iCT
11 February 2026Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
Good governance when implementing natalizumab biosimilar
11 December 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.
Exagamglogene autotemcel (Casgevy®)
13 February 2026This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of exagamglogene autotemcel.
National Homecare Medicines Committee (NHMC) managing complaints and incidents within homecare services - Appendix 19 training
2 July 2018Find and download the NHMC managing homecare complaints and incidents workbook
National Homecare Medicines Committee (NHMC) Homecare Risk Assessment
10 December 2019Find attached the homecare risk assessment spreadsheet to download
National Homecare Medicines Committee (NHMC) Proposal for the funding of Pharmacy Homecare Teams
4 May 2018Find the proposal for the funding of Pharmacy Homecare Teams document
NHMC Good Practice Principles for the Provision of Manufacturer Funded Homecare Services
5 March 2018Find attached the good practice principles for manufacturers offering manufacturer funded homecare medicine services
Preparing to use ranibizumab biosimilar
5 November 2025Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
Preparing to use golimumab biosimilar
21 July 2026One golimumab biosimilar (Gobivaz) is available. We offer general information and implementation advice.